[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Pages 427-428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00197]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public, limited only by room 
seating. The meeting room accommodates 216 for public seating. Rooms 
245, 246, and 247, adjacent to the meeting room, will be available once 
the meeting room reaches capacity, providing up to 120 additional 
seats. Time will be available for public comment. The meeting will be 
webcast live via the World Wide Web; for instructions and more 
information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html.

DATES: The meeting will be held on February 27, 2019, 8:00 a.m. to 5:30 
p.m., EST, and February 28, 2019, 8:30 a.m. to 3:30 p.m. EST.

ADDRESSES: CDC, 1600 Clifton Road, NE, Tom Harkin Global Communications 
Center, Building 19, Kent `Oz' Nelson Auditorium, Atlanta, Georgia 
30329-4027.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, CDC, NCIRD, telephone 404-639-8836, email 
<a href="/cdn-cgi/l/email-protection#e9a8aaa0b9a98a8d8ac78e869f"><span class="__cf_email__" data-cfemail="28696b6178684b4c4b064f475e">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.

Public Comment

    Oral Public Comment: This meeting will include one 75-minute 
session for oral public comment during which members of the public may 
make an in-person public comment. The oral public comment session will 
occur near the end of the first day's session on February 27, 2019 and 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines for Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below. 
On-site, in-person registration for oral public comment at the meeting 
will only be available if there is time remaining in the oral public 
comment session after all individuals who submitted a request to make 
an oral comment before the meeting have had an opportunity to speak. 
There is no guarantee there will be an opportunity for on-site, in-
person registration for oral public comment, and all individuals 
interested in requesting to make an oral public comment are strongly 
encouraged to submit a request according to the instructions below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the February ACIP meeting must submit a 
request at http://www.cdc.gov/vaccines/acip/meetings/ no later than 
11:59 p.m., EDT, February 13, 2019. Interested persons must include 
their name; the name of the group or organization the individual is 
representing, if applicable; and contact information, including email 
address, mailing address, and telephone number.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled 75-minute oral public 
comment session, CDC will conduct a lottery to determine the speakers 
for the scheduled session. CDC staff will notify individuals regarding 
their request to speak by email by February 15, 2019. To accommodate 
the significant interest in participation in the oral public comment 
session of ACIP meetings, each speaker will be limited to 3 minutes, 
and each speaker may only speak once per meeting. Interested persons 
who are unable to make an oral public comment during this meeting are 
invited to submit a written comment according to the instructions 
below.
    Written Public Comment: Written comments will be accepted up to 48 
hours following the end of the ACIP Meeting. You may submit comments,

[[Page 428]]

identified by Docket No. CDC-201x-xxxx using the Federal eRulemaking 
Portal: http://www.regulations.gov. Follow the instructions for 
submitting comments. All submissions received must include the agency 
name and Docket Number. All relevant comments received in conformance 
with the regulations.gov suitability policy will be posted without 
change to http://regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov. Written public 
comments submitted by 72 hours prior to the ACIP meeting will be 
provided to the ACIP members before the meeting.
    Matters to be Considered: The agenda will include discussions on 
human papillomavirus vaccines, pneumococcal vaccines, Japanese 
encephalitis vaccines, influenza vaccines, anthrax vaccine, hepatitis 
vaccines, Pertussis vaccine, herpes zoster vaccine, and meningococcal 
vaccines. A recommendation vote is scheduled for anthrax vaccine, 
Japanese encephalitis vaccines, and human papillomavirus vaccines. 
Agenda items are subject to change as priorities dictate. For more 
information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00197 Filed 1-25-19; 8:45 am]
 BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>